RIZZO, Manfredi
 Distribuzione geografica
Continente #
NA - Nord America 38.080
EU - Europa 17.509
AS - Asia 16.466
SA - Sud America 3.382
Continente sconosciuto - Info sul continente non disponibili 2.310
AF - Africa 454
OC - Oceania 45
Totale 78.246
Nazione #
US - Stati Uniti d'America 37.129
SG - Singapore 5.989
RU - Federazione Russa 4.433
IT - Italia 4.153
CN - Cina 3.734
BR - Brasile 2.592
VN - Vietnam 1.759
HK - Hong Kong 1.676
DE - Germania 1.629
FI - Finlandia 1.600
PL - Polonia 1.275
UA - Ucraina 1.101
GB - Regno Unito 934
FR - Francia 830
JP - Giappone 806
BD - Bangladesh 524
CA - Canada 463
IE - Irlanda 449
KR - Corea 400
IN - India 288
SE - Svezia 271
AR - Argentina 213
NL - Olanda 199
MX - Messico 198
CO - Colombia 159
IQ - Iraq 155
TR - Turchia 147
EC - Ecuador 141
ID - Indonesia 120
AT - Austria 117
UZ - Uzbekistan 98
RO - Romania 95
ZA - Sudafrica 89
PK - Pakistan 88
MY - Malesia 83
VE - Venezuela 82
MA - Marocco 78
ES - Italia 77
CI - Costa d'Avorio 75
PH - Filippine 68
SA - Arabia Saudita 63
JM - Giamaica 62
PY - Paraguay 56
IR - Iran 54
BE - Belgio 48
CL - Cile 46
CR - Costa Rica 46
JO - Giordania 44
TH - Thailandia 44
EG - Egitto 41
KE - Kenya 41
NP - Nepal 39
CZ - Repubblica Ceca 38
LB - Libano 38
GR - Grecia 37
DZ - Algeria 36
AE - Emirati Arabi Uniti 35
AU - Australia 35
CH - Svizzera 33
IL - Israele 32
HN - Honduras 31
PE - Perù 31
UY - Uruguay 31
EE - Estonia 29
AZ - Azerbaigian 26
BO - Bolivia 26
KZ - Kazakistan 25
TW - Taiwan 22
TN - Tunisia 21
PA - Panama 20
AL - Albania 19
NI - Nicaragua 19
BH - Bahrain 18
GT - Guatemala 18
DO - Repubblica Dominicana 17
BG - Bulgaria 15
ET - Etiopia 15
RS - Serbia 15
TT - Trinidad e Tobago 15
HR - Croazia 14
KG - Kirghizistan 14
LT - Lituania 14
SV - El Salvador 14
YE - Yemen 13
DK - Danimarca 12
PR - Porto Rico 12
EU - Europa 11
PT - Portogallo 11
SN - Senegal 11
PS - Palestinian Territory 10
HU - Ungheria 9
NZ - Nuova Zelanda 9
SY - Repubblica araba siriana 9
XK - ???statistics.table.value.countryCode.XK??? 9
BA - Bosnia-Erzegovina 8
BB - Barbados 8
BY - Bielorussia 7
MD - Moldavia 7
OM - Oman 7
A2 - ???statistics.table.value.countryCode.A2??? 6
Totale 75.813
Città #
Ashburn 4.652
Singapore 3.868
San Jose 3.438
Fairfield 3.273
Woodbridge 1.612
Hong Kong 1.597
Chandler 1.594
Houston 1.442
Wilmington 1.426
Seattle 1.249
Zgierz 1.171
Cambridge 1.038
Council Bluffs 1.008
Tokyo 785
Santa Clara 736
Moscow 720
Palermo 718
Ann Arbor 696
Medford 685
Ho Chi Minh City 563
Los Angeles 544
Beijing 517
Frankfurt am Main 514
Dallas 510
Lauterbourg 510
Jacksonville 449
Dublin 445
Altamura 441
Princeton 440
Hanoi 420
New York 418
Nanjing 380
Hefei 345
Chicago 339
Helsinki 320
Des Moines 316
Lawrence 293
Boardman 282
Milan 268
São Paulo 259
San Diego 248
Dearborn 228
Buffalo 210
Rome 187
Tulsa 186
London 159
Nuremberg 148
Columbus 145
Orem 133
Ludwigshafen am Rhein 131
Toronto 131
Atlanta 129
Shenyang 128
Hebei 125
Nanchang 117
Phoenix 115
Amsterdam 106
Da Nang 102
Changsha 99
Tianjin 95
Jiaxing 91
Brooklyn 90
Denver 89
Jinan 88
The Dalles 83
Lappeenranta 81
Rio de Janeiro 77
Tashkent 77
Abidjan 75
Haiphong 75
Naples 75
Montreal 74
Seongnam 73
Warsaw 73
Guangzhou 72
San Francisco 72
Brasília 69
Verona 65
Munich 63
Zhengzhou 58
Saint Petersburg 57
Krefeld 56
Curitiba 55
Philadelphia 54
Belo Horizonte 53
Paris 53
Baghdad 52
Ningbo 52
Chennai 51
Dhaka 50
Boston 49
Cardiff 49
Johannesburg 48
Shanghai 47
Washington 47
San Paolo di Civitate 45
Vienna 45
Guayaquil 44
Miami 44
Orange 44
Totale 45.718
Nome #
The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials 541
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE 483
Oral manifestations of inflammatory bowel disease 474
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 443
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet 332
Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. 324
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease 309
Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis 296
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size 291
Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography 286
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 285
A NOVEL THERAPEUTIC APPROACH TO COLORECTAL CANCER IN DIABETES: ROLE OF METFORMIN AND RAPAMYCIN 282
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 275
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. 275
Who needs to care about small, dense low density lipoproteins? 270
A case of bowel schistosomiasis that did not adhere to the endoscopic findings. 268
The Role of Nutraceuticals in Statin Intolerant Patients 263
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction 262
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 262
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 257
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. 256
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 256
Serum low density lipoprotein subclasses in asthma 254
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 254
INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY 249
Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. 245
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 244
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions 243
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 241
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 239
Efficacy of a fasting‐mimicking diet in functional therapy for depression: A randomised controlled pilot trial 237
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome 235
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 230
Fever of unknown origin in a mediterranean survey from a division of internal medicine: report of 91 cases during a twelve-year-period (1991-2002) 228
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study 227
Management of Statin Intolerance in 2018: Still More Questions Than Answers 227
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease 226
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 226
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam 226
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 222
Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. 220
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 219
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 219
Heat Shock Protein-60 and Risk for Cardiovascular Disease. 219
The atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 218
Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis 217
Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. 216
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. 216
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. 215
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 215
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases 214
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. 212
High resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. 212
Therapeutic patient education in oncology: pedagogical notions for women's health and prevention. 212
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 212
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels 211
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 211
An update on the role of markers of inflammation in atherosclerosis 210
A practical method to determine the “atherogenic lipoprotein phenotype” 210
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. 209
Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction 208
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 208
Medical therapy for patients with subclinical and clinical carotid atherosclerosis 207
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome 207
Emerging approaches for the treatment of hypertriglyceridemia. 206
The malnutrition in the elderly: a clinical approach. 205
Febbre di origine sconosciuta (FUO): due casisitiche di una medesima divisione di medicina interna a confronto 204
A Potential Link between Serum Low-Density Lipoproteins and Asthma 204
PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP 203
Le LDL generate in fase post-prandiale dopo carico grasso presentano maggiore densita’, minore size e maggiore affinita’ per il recettore 203
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome 202
Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. 202
Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study 201
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. 201
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 200
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? 199
The effect of bergamot on dyslipidemia 198
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 197
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 197
Effects of aging and diet on cardioprotection and cardiometabolic risk markers 197
Anti-cytokine therapy for prevention of atherosclerosis 197
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 195
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 195
Androgen excess and cardiovascular risk. 194
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 194
LA PRESENZA DI ELEVATI LIVELLI DI FIBRINOGENO E PROTEINA C-REATTIVA SONO SIGNIFICATIVAMENTE ASSOCIATI ALLA PRESENZA DI ATEROSCLEROSI CAROTIDEA NEI PAZIENTI IPERTESI O DIABETICI. 193
Small, dense low-density-lipoproteins and the metabolic syndrome. 193
NUTRACEUTICALS IMPROVE EXPERIMENTAL COLITIS: PLACE OF CATECHINS IN THE 2,4,6-TRINITROBENZENE SULFONIC ACID MODEL RATS 193
The clinical significance of small, dense low-density lipoproteins 192
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 mesi su primi 100 pazienti 192
La vitamina D in pazienti adulti affetti da talassemia major 192
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates 191
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 190
Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors. 189
Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR 188
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 187
Atherogenic dyslipidemia and oxidative stress: a new look 187
The role of small, dense low-density lipoproteins in non-coronary forms of atherosclerosis. 186
Should we measure routinely the LDL peak particle size? 186
Oxidative stress markers at birth: Analyses of a neonatal population 186
Totale 23.399
Categoria #
all - tutte 291.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.248 0 0 0 184 112 126 182 210 489 857 209 879
2022/20235.637 591 1.037 73 461 667 740 262 430 906 59 316 95
2023/20242.858 137 354 191 231 237 712 321 204 71 88 73 239
2024/20258.958 299 719 764 826 269 201 786 637 683 1.029 841 1.904
2025/202628.573 1.553 876 1.895 2.335 2.145 3.454 4.021 3.101 2.961 4.048 1.275 909
2026/20278.766 1.536 1.746 4.538 946 0 0 0 0 0 0 0 0
Totale 78.246